Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer

Clinical trial NCT07506876 · RECRUITING

Trial details

NCT number: NCT07506876
Sponsor: Legacy Health System
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer - Infiltrating Ductal Carcinoma HER-2 Positive Breast Cancer

Start date: 2026-04-27
Primary completion: 2027-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.